Invesaro

Companies LXEO 8-K

SEC filing · 8-K

Lexeo Therapeutics, Inc.: Acquisition or sale completed

Lexeo Therapeutics completed the acquisition of Mantle Therapeutics.

Filed September 29, 2026

Positive for the company

What happened

  • On September 29, 2026, Lexeo Therapeutics completed its acquisition of Mantle Therapeutics.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Back to Lexeo Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.